ADVM
Price
$2.71
Change
-$0.10 (-3.56%)
Updated
May 12 closing price
Capitalization
58.7M
BEAM
Price
$18.24
Change
+$0.83 (+4.77%)
Updated
May 12 closing price
Capitalization
1.75B
91 days until earnings call
Ad is loading...

ADVM vs BEAM

Header iconADVM vs BEAM Comparison
Open Charts ADVM vs BEAMBanner chart's image
Adverum Biotechnologies
Price$2.71
Change-$0.10 (-3.56%)
Volume$621.59K
Capitalization58.7M
Beam Therapeutics
Price$18.24
Change+$0.83 (+4.77%)
Volume$2.23M
Capitalization1.75B
ADVM vs BEAM Comparison Chart
Loading...
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADVM vs. BEAM commentary
May 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADVM is a StrongBuy and BEAM is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 13, 2025
Stock price -- (ADVM: $2.71 vs. BEAM: $18.24)
Brand notoriety: ADVM and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADVM: 190% vs. BEAM: 79%
Market capitalization -- ADVM: $58.7M vs. BEAM: $1.75B
ADVM [@Biotechnology] is valued at $58.7M. BEAM’s [@Biotechnology] market capitalization is $1.75B. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADVM’s FA Score shows that 0 FA rating(s) are green whileBEAM’s FA Score has 0 green FA rating(s).

  • ADVM’s FA Score: 0 green, 5 red.
  • BEAM’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than ADVM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADVM’s TA Score shows that 3 TA indicator(s) are bullish while BEAM’s TA Score has 5 bullish TA indicator(s).

  • ADVM’s TA Score: 3 bullish, 5 bearish.
  • BEAM’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than ADVM.

Price Growth

ADVM (@Biotechnology) experienced а -24.51% price change this week, while BEAM (@Biotechnology) price change was -7.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.48%. For the same industry, the average monthly price growth was +10.12%, and the average quarterly price growth was -9.68%.

Reported Earning Dates

ADVM is expected to report earnings on Apr 15, 2025.

BEAM is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-3.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.75B) has a higher market cap than ADVM($58.7M). BEAM YTD gains are higher at: -26.452 vs. ADVM (-41.970). ADVM has higher annual earnings (EBITDA): -99.25M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. ADVM (153M). ADVM has less debt than BEAM: ADVM (73.3M) vs BEAM (158M). BEAM has higher revenues than ADVM: BEAM (63.6M) vs ADVM (1M).
ADVMBEAMADVM / BEAM
Capitalization58.7M1.75B3%
EBITDA-99.25M-399.03M25%
Gain YTD-41.970-26.452159%
P/E RatioN/AN/A-
Revenue1M63.6M2%
Total Cash153M1.22B13%
Total Debt73.3M158M46%
FUNDAMENTALS RATINGS
ADVM: Fundamental Ratings
ADVM
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADVMBEAM
RSI
ODDS (%)
Bullish Trend 1 day ago
76%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
68%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
View a ticker or compare two or three
Ad is loading...
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIRAX9.71N/A
N/A
Fidelity Advisor Intl Real Estate A
WFDSX29.45N/A
N/A
Allspring SMID Cap Growth Fund - Cl Inst
SOAAX8.77N/A
N/A
Spirit of America Real Estate Inc & Gr A
FAYZX13.84N/A
N/A
Fidelity Advisor Multi-Asset Income I
RGGHX37.57N/A
N/A
American Funds Global Balanced R2E

ADVM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADVM has been loosely correlated with IMNM. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ADVM jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADVM
1D Price
Change %
ADVM100%
-3.56%
IMNM - ADVM
45%
Loosely correlated
+6.43%
CCCC - ADVM
45%
Loosely correlated
+7.48%
KYMR - ADVM
44%
Loosely correlated
+6.98%
ETNB - ADVM
43%
Loosely correlated
+5.32%
TENX - ADVM
43%
Loosely correlated
+2.51%
More

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+4.77%
CRSP - BEAM
72%
Closely correlated
+5.53%
NTLA - BEAM
66%
Loosely correlated
+5.30%
RXRX - BEAM
63%
Loosely correlated
+7.16%
PRME - BEAM
59%
Loosely correlated
+3.08%
VERV - BEAM
58%
Loosely correlated
+2.84%
More